232 results on '"Veldeman, L."'
Search Results
2. Genetically-based Cox-NTCP models for late toxicity after prostate cancer RT
3. GENETICALLY-BASED COX-NTCP MODELS FOR LATE TOXICITY AFTER PROSTATE CANCER RT
4. PO-2025 Reconstructing dose distributions from manually planned electron boosts in breast radiotherapy
5. MO-0056 NTCP Models for Late Tissue Fibrosis Following Breast RT are Validated in a Large Prospective Cohort
6. OC-0608 Do patients with lung cancer and a genetic risk for rheumatoid arthritis have increased toxicity?
7. OC-0510 Genetically-based Cox-NTCP models for late toxicity after prostate cancer RT
8. CO-04.5 - GENETICALLY-BASED COX-NTCP MODELS FOR LATE TOXICITY AFTER PROSTATE CANCER RT
9. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
10. Radiotherapy including a boost should be delivered over no more than 3–4 weeks invited article for the Breast's upcoming SI “de-escalation of loco-regional treatment in breast cancer: Time to find the balance?” the role of the radiation therapy breast boost in the 2020s
11. Prostate Cancer Patients with a High Polygenic Risk of Rheumatoid Arthritis have Increased Radiotherapy Toxicity
12. Genome wide association study of long-term patient-reported outcomes following radiotherapy for breast cancer – results from the REQUITE cohort study
13. Prone left-sided whole-breast irradiation: Significant heart dose reduction using end-inspiratory versus end-expiratory gating
14. PD-0174 Atlas-based auto-contouring of breast tissue in young female lymphoma patients
15. MO-0557 Estimates of α/β ratios for individual late urinary toxicity endpoints: analysis of a cohort trial
16. MO-0386 Treatment time and circadian genotype interact to alter the severity of radiotherapy side-effects
17. MO-0804 Determinants of fatigue and longitudinal changes up to 2 years post-radiotherapy for breast cancer
18. MO-0801 Machine learning based models of radiotherapy-induced skin induration for breast cancer patients
19. OC-0135 Predicting patient-reported symptom clusters in lung cancer patients: a machine learning approach
20. Predicting patient-reported symptom clusters in prostate cancer patients: A machine learning approach
21. PH-0656 Prediction of toxicity after prostate cancer RT: the value of a SNP-interaction polygenic risk score
22. PD-0925 An European cross-cultural analysis of worsening of functional scales in prostate cancer patients after RT
23. PD-0766 Impact of treatment and clinical factors on worsening of functional scales after prostate cancer RT
24. PO-1095 Reducing overall treatment time, a pilot RCT of neo-adjuvant radiotherapy in early breast cancer
25. PO-1108 Deep inspiration breath hold in prone photon or proton irradiation of breast and lymph nodes
26. PO-1917 Circadian rhythm effects on radiotherapy toxicity
27. Reproducibility of Repeated Breathhold and Impact of Breathhold Failure in Whole Breast and Regional Nodal Irradiation in Prone Crawl Position
28. P074 - Genetically-based Cox-NTCP models for late toxicity after prostate cancer RT
29. PD-0235 Variation in incidental dose to the axilla in patients treated with whole breast radiotherapy alone
30. PO-1259: Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre
31. Genome wide association study of acute radiation toxicity and quality of life in breast cancer patients – results from the REQUITE cohort study
32. 121 (PB-034) Poster - Genome wide association study of long-term patient-reported outcomes following radiotherapy for breast cancer – results from the REQUITE cohort study
33. A1153 - Predicting patient-reported symptom clusters in prostate cancer patients: A machine learning approach
34. Requite: Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality-of-Life in Cancer Survivors
35. Requite Prostate Cohort: Validating Clinical/Dosimetric/Genetic Risk Factors for Late Urinary Toxicity
36. OC-0161 Validation of clinical/dosimetric/genetic risk factor models for late RT-induced rectal bleeding
37. EP-1663 REQUITE multicentre study of patients undergoing radiotherapy for breast, lung or prostate cancer
38. OC-0647 Analysis of biomarkers for late radiotherapy toxicity in the REQUITE project
39. OC-0154: REQUITE Big Data Resource for Validating Predictive Models and Biomarkers of Radiotherapy Toxicity
40. Acute toxicity and quality of life in breast cancer patients treated by radiotherapy – results from the REQUITE multi-centre cohort study
41. SP-0563: Prone whole-breast irradiation: are the benefits overshadowed by the challenges?
42. SP-0483: The REQUITE project: integrating biomarkers and clinical predictors of radiotherapy side effects
43. OC-0191: Improved set-up accuracy for adjuv ant whole breast irradiation in the prone-crawl position
44. 17 Oral - Genome wide association study of acute radiation toxicity and quality of life in breast cancer patients – results from the REQUITE cohort study
45. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study
46. EP-1487: Dosimetric aspects in the development of a crawl positioning device for prone breast radiotherapy
47. OC-0374 GWAS identifies new susceptibility loci for late toxicity following prostate cancer radiotherapy
48. O39. In vitro cellular radiosensitivity assays as predictor of radiotherapy related late toxicity in breast cancer patients
49. OC-0141: Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation?
50. PO-0789: Treatment time in breast irradiation: a trade-off between positioning and complexity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.